Prostate News Archive
18-Oct-2007
Hyperthermia Combined with Radiation and Androgen Therapy Provides Positive Results with Reduced Toxicity for Prostate ... (Business Wire via Yahoo! Finance)
SALT LAKE CITY----BSD Medical Corp. today announced that the International Journal of Hyperthermia has published the preliminary results of a phase II clinical study involving 144 patients with locally advanced prostate cancer. Cancer screening saves lives (Deseret Morning News)
All that nagging by public health officials is paying handsome dividends: Cancer deaths are dropping, due in part to increased use of colonoscopies, mammograms and other screening tests for colorectal and prostate cancer. Bioxell mulls marketing partnership for key prostate drug Elocalcitol (Sharewatch)
ZURICH (Thomson Financial) - Bioxell SpA is currently considering forming a partnership to market its key prostate drug Elocalcitol, said CEO Francesco Sinigaglia speaking at the pharmaceutical group's R&D day in Zurich. (AFX UK Focus) 2007-10-17 14:00 GMT: Bioxell mulls marketing partnership for key prostate drug Elocalcitol UPDATE (Interactive Investor)
(Updates with further comment from company, market value estimate) Nicotine patch for prostate surgery relief? (News-Medical-Net)
The use of a nicotine patch - successfully used to help many smokers decrease their dependency on nicotine - was shown to reduce pain in men after prostate removal surgery in a new anesthesiology study.
Back to Prostate News Archive
